Literature DB >> 20123667

Regional variation in carotid artery stenting and endarterectomy in the Medicare population.

Philip P Goodney1, Lori L Travis, David Malenka, Kristen K Bronner, F Lee Lucas, Jack L Cronenwett, David C Goodman, Elliott S Fisher.   

Abstract

BACKGROUND: To describe geographic variation in population-based rates of carotid artery stenting (CAS) and carotid endarterectomy (CEA) performed in Medicare beneficiaries. METHODS AND
RESULTS: Medicare claims and enrollment data were used to calculate age, sex, and race-adjusted rates of CAS and CEA for Medicare beneficiaries in each of 306 hospital referral regions between 1998 and 2007. Procedures were identified using a combination of Current Procedural Terminology codes as well as diagnostic and procedural ICD-9 codes. Overall, the rate of carotid revascularization has fallen slightly over the last decade (3.8 procedures per 1000 in 1998, 3.1 procedures per 1000 in 2007; P<0.0001). Although the use of CEA decreased, from 3.6 to 2.5 procedures per 1000 beneficiaries in 2007 (P<0.0001), the use of CAS has increased >4-fold between 1998 and 2007, growing from 0.1 to 0.6 CAS procedures per 1000 beneficiaries (P<0.0001). Further, CAS rapidly disseminated across the country over the last decade. In 1998, 66% of hospital referral regions had a hospital that performed CAS; however, by 2007, nearly all (95%) hospital referral regions performed CAS (P<0.0001). Last, in regions with the highest utilization rates of CAS, it appeared that CAS was performed as a substitute for CEA. There was little evidence that CAS was being performed in addition to CEA, as no correlation existed between regional rates of CAS and CEA (r=0.06).
CONCLUSIONS: Even though CEA was used less frequently in 2007 than 1998, the use of CAS has grown significantly. Although regional variation in the use of CEA has remained fairly constant, regional variation has increased in the use of CAS. Given these changes in practice patterns, careful examination of the efficacy and cost-effectiveness of CAS is necessary.

Entities:  

Mesh:

Year:  2009        PMID: 20123667      PMCID: PMC5240818          DOI: 10.1161/CIRCOUTCOMES.109.864736

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  42 in total

1.  Cardiologists performing peripheral angioplasties: impact on utilization.

Authors:  D A Axelrod; A M Fendrick; J D Birkmeyer; D E Wennberg; A E Siewers
Journal:  Eff Clin Pract       Date:  2001 Sep-Oct

Review 2.  [Asymptomatic carotid stenoses. A cardiologist's viewpoint].

Authors:  L Goullard; A Gommeaux; P Poncelet; D Lenica; P Durand; C Dieux
Journal:  Ann Cardiol Angeiol (Paris)       Date:  2004-01

3.  Variations in hospital resource use for Medicare and privately insured populations in California.

Authors:  Laurence C Baker; Elliott S Fisher; John E Wennberg
Journal:  Health Aff (Millwood)       Date:  2008-02-12       Impact factor: 6.301

4.  Atherosclerotic Peripheral Vascular Disease Symposium II: controversies in carotid artery revascularization.

Authors:  Christopher J White; Joshua A Beckman; Richard P Cambria; Anthony J Comerota; William A Gray; Robert W Hobson; Sriram S Iyer
Journal:  Circulation       Date:  2008-12-16       Impact factor: 29.690

5.  Relationship between the regional and national incidence of transient ischaemic attack and stroke and performance of carotid endarterectomy.

Authors:  R G Gibbs; J C Todd; C Irvine; R Lawrenson; R Newson; R M Greenhalgh; A H Davies
Journal:  Eur J Vasc Endovasc Surg       Date:  1998-07       Impact factor: 7.069

6.  Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics.

Authors:  D E Wennberg; F L Lucas; J D Birkmeyer; C E Bredenberg; E S Fisher
Journal:  JAMA       Date:  1998 Apr 22-29       Impact factor: 56.272

7.  Regional variations in health care intensity and physician perceptions of quality of care.

Authors:  Brenda E Sirovich; Daniel J Gottlieb; H Gilbert Welch; Elliott S Fisher
Journal:  Ann Intern Med       Date:  2006-05-02       Impact factor: 25.391

8.  Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase.

Authors:  Robert W Hobson; Virginia J Howard; Gary S Roubin; Thomas G Brott; Robert D Ferguson; Jeffrey J Popma; Darlene L Graham; George Howard
Journal:  J Vasc Surg       Date:  2004-12       Impact factor: 4.268

9.  Changing patterns in the practice of carotid endarterectomy in a large metropolitan area.

Authors:  T G Brott; R J Labutta; R F Kempczinski
Journal:  JAMA       Date:  1986-05-16       Impact factor: 56.272

10.  Opening of specialty cardiac hospitals and use of coronary revascularization in medicare beneficiaries.

Authors:  Brahmajee K Nallamothu; Mary A M Rogers; Michael E Chernew; Harlan M Krumholz; Kim A Eagle; John D Birkmeyer
Journal:  JAMA       Date:  2007-03-07       Impact factor: 56.272

View more
  24 in total

1.  Variation in the use of lower extremity vascular procedures for critical limb ischemia.

Authors:  Philip P Goodney; Lori L Travis; Brahmajee K Nallamothu; Kerianne Holman; Bjoern Suckow; Peter K Henke; F Lee Lucas; David C Goodman; John D Birkmeyer; Elliott S Fisher
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-12-06

2.  US cardiologist workforce from 1995 to 2007: modest growth, lasting geographic maldistribution especially in rural areas.

Authors:  Sanjay Aneja; Joseph S Ross; Yongfei Wang; Masatoshi Matsumoto; George P Rodgers; Susannah M Bernheim; Saif S Rathore; Harlan M Krumholz
Journal:  Health Aff (Millwood)       Date:  2011-12       Impact factor: 6.301

3.  Operator experience and carotid stenting outcomes in Medicare beneficiaries.

Authors:  Brahmajee K Nallamothu; Hitinder S Gurm; Henry H Ting; Philip P Goodney; Mary A M Rogers; Jeptha P Curtis; Justin B Dimick; Eric R Bates; Harlan M Krumholz; John D Birkmeyer
Journal:  JAMA       Date:  2011-09-28       Impact factor: 56.272

4.  Medicare's policy on carotid stents limited use to hospitals meeting quality guidelines yet did not hurt disadvantaged.

Authors:  Peter W Groeneveld; Andrew J Epstein; Feifei Yang; Lin Yang; Daniel Polsky
Journal:  Health Aff (Millwood)       Date:  2011-02       Impact factor: 6.301

Review 5.  Roles for specialty societies and vascular surgeons in accountable care organizations.

Authors:  Philip P Goodney; Elliott S Fisher; Richard P Cambria
Journal:  J Vasc Surg       Date:  2012-03       Impact factor: 4.268

6.  Physician specialty and variation in carotid revascularization technique selected for Medicare patients.

Authors:  Jessica B Wallaert; Brian W Nolan; David H Stone; Richard J Powell; Jeremiah R Brown; Jack L Cronenwett; Philip P Goodney
Journal:  J Vasc Surg       Date:  2015-10-01       Impact factor: 4.268

7.  National trends and regional variation of open and endovascular repair of thoracic and thoracoabdominal aneurysms in contemporary practice.

Authors:  Salvatore T Scali; Philip P Goodney; Daniel B Walsh; Lori L Travis; Brian W Nolan; David C Goodman; F Lee Lucas; David H Stone
Journal:  J Vasc Surg       Date:  2011-06       Impact factor: 4.268

8.  Completion of guideline-recommended initial evaluation of atrial fibrillation.

Authors:  Moritz F Sinner; Melissa A Greiner; Xiaojuan Mi; Adrian F Hernandez; Paul N Jensen; Jonathan P Piccini; Soko Setoguchi; Allan J Walkey; Susan R Heckbert; Emelia J Benjamin; Lesley H Curtis
Journal:  Clin Cardiol       Date:  2012-09-13       Impact factor: 2.882

9.  Physician specialty and carotid stenting among elderly medicare beneficiaries in the United States.

Authors:  Brahmajee K Nallamothu; Mingrui Lu; Mary A M Rogers; Hitinder S Gurm; John D Birkmeyer
Journal:  Arch Intern Med       Date:  2011-08-08

10.  Effect of hospital-level variation in the use of carotid artery stenting versus carotid endarterectomy on perioperative stroke and death in asymptomatic patients.

Authors:  Theodore H Yuo; Howard S Degenholtz; Rabih A Chaer; Kevin L Kraemer; Michel S Makaroun
Journal:  J Vasc Surg       Date:  2013-01-09       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.